Choose timezone
Your profile timezone:
The lecture will give an overview on the medical isotope production at the FRM II and on our worldwide net of usable research reactors, on the production of carrier-free Lu-177 by irradiation of enriched Yb-176 and on the principle of targeted radionuclide therapy. Overall we have reached in 2021 a production of nearly 100.000 patient doses.
Dr. Jitae Park
Dr. Theresia Heiden-Hecht